Driving the growth of the Oncology Development team, including strategic medical oversight, Siri brings over 20 years of leadership and clinical development expertise, having held senior positions at Nykode Therapeutics, AstraZeneca, and Novartis.

As a board-certified oncology specialist, Siri has deep experience in oncology and immuno-oncology clinical development and medical strategy, spanning early to late-phase trials. She has also contributed to infectious disease development programs and autoimmune preclinical development.

Siri is passionate about translating scientific innovation into meaningful clinical outcomes and building high-performing development teams focused on patient impact.